ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 569,45
-0,83%
Dow Jones
40 211,72
0,00%
DAX
18 483,46
-0,63%
Brent Oil
83,065
-1,51%
Bitcoin
63 808,01
-1,61%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Insmed Inc (INSM)

  7. Insmed Inc (INSM) Actualités

INSM

Insmed (INSM)

Insmed Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:INSM
DateHeureSourceTitreSymboleSociété
28/09/201823h58GlobeNewswire Inc.Insmed Announces FDA Approval of ARIKAYCE® (amikacin liposome inhalation suspension), the First and Only Therapy Specificall...NASDAQ:INSMInsmed Inc
17/09/201822h19Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INSMInsmed Inc
17/09/201814h00GlobeNewswire Inc.Pivotal Phase 3 Data from CONVERT Study of ALIS in Patients with Treatment-Refractory NTM Lung Disease Caused by MAC Publishe...NASDAQ:INSMInsmed Inc
10/08/201818h34Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:INSMInsmed Inc
09/08/201822h16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INSMInsmed Inc
07/08/201823h30GlobeNewswire Inc.FDA Advisory Committee Votes 12-2 in Favor of the Safety and Effectiveness of Insmed’s ALIS for the Treatment of NTM Lung D...NASDAQ:INSMInsmed Inc
02/08/201814h01Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:INSMInsmed Inc
02/08/201813h30GlobeNewswire Inc.Insmed Reports Second Quarter 2018 Financial Results and Provides Business UpdateNASDAQ:INSMInsmed Inc
26/07/201814h00GlobeNewswire Inc.Insmed to Host Second Quarter 2018 Financial Results Conference Call on Thursday, August 2, 2018NASDAQ:INSMInsmed Inc
15/06/201814h00GlobeNewswire Inc.Insmed Announces FDA Advisory Committee Meeting to Review ALIS as a treatment for NTM Lung Disease Caused by MACNASDAQ:INSMInsmed Inc
07/06/201814h00GlobeNewswire Inc.Insmed to Present at Three June ConferencesNASDAQ:INSMInsmed Inc
31/05/201822h27Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:INSMInsmed Inc
22/05/201823h15GlobeNewswire Inc.Insmed Announces Presentations at the American Thoracic Society 2018 International ConferenceNASDAQ:INSMInsmed Inc
17/05/201822h19Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:INSMInsmed Inc
17/05/201822h05GlobeNewswire Inc.Insmed Appoints Leo Lee to its Board of DirectorsNASDAQ:INSMInsmed Inc
16/05/201814h00GlobeNewswire Inc.Insmed Announces FDA Acceptance for Filing of New Drug Application for ALIS in NTM Lung Disease Caused by MACNASDAQ:INSMInsmed Inc
02/05/201815h21GlobeNewswire Inc.Insmed to Present at the Deutsche Bank 43rd Annual Health Care ConferenceNASDAQ:INSMInsmed Inc
02/05/201813h30GlobeNewswire Inc.Insmed Reports First Quarter 2018 Financial Results and Provides Business UpdateNASDAQ:INSMInsmed Inc
25/04/201814h00GlobeNewswire Inc.Insmed to Host First Quarter 2018 Financial Results Conference Call on Wednesday, May 2, 2018NASDAQ:INSMInsmed Inc
05/04/201818h59Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:INSMInsmed Inc
05/04/201818h57Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:INSMInsmed Inc
29/03/201814h00GlobeNewswire Inc.Insmed Submits New Drug Application to FDA for ALIS in NTM Lung Disease Caused by MACNASDAQ:INSMInsmed Inc
27/03/201822h30Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:INSMInsmed Inc
07/03/201814h00GlobeNewswire Inc.Insmed to Present at the Cowen and Company 38th Annual Health Care ConferenceNASDAQ:INSMInsmed Inc
23/02/201814h03Edgar (US Regulatory)Annual Report (10-k)NASDAQ:INSMInsmed Inc
23/02/201813h30GlobeNewswire Inc.Insmed Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business UpdateNASDAQ:INSMInsmed Inc
21/02/201823h26GlobeNewswire Inc.Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:INSMInsmed Inc
20/02/201814h00GlobeNewswire Inc.Insmed Extends ALIS Intellectual Property Protection to 2035 with Issuance of Ninth U.S. PatentNASDAQ:INSMInsmed Inc
15/02/201814h00GlobeNewswire Inc.Insmed to Host Fourth Quarter and Full Year 2017 Financial Results Conference Call on Friday, February 23, 2018NASDAQ:INSMInsmed Inc
12/02/201823h19Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:INSMInsmed Inc
 Showing the most relevant articles for your search:NASDAQ:INSM

Dernières Valeurs Consultées

EU
SGO
Cie de SaintGobain
EU
CAP
Capgemini
NASDAQ
AAPL
Apple
NASDAQ
MSFT
Microsoft
EU
RI
Pernod Ricard
EU
RNO
Renault
EU
BNP
BNP Paribas
NYSE
JPM
JP Morgan Chase
EU
ML
Michelin
COIN
BTCUSD
Bitcoin
COIN
ETHUSD
Ethereum
EU
CS
Axa
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés